Innovative Cardiac Technologies, LLC – Trademark Portfolio

Entity Type: 16

Innovative Cardiac Technologies, LLC has 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Filings span 4 Nice Classification classes, led by Class 10 (Medical Apparatus) and Class 42 (Computer & Scientific). This trademark owner is based in Atlanta, GA.

1001 DeFoors Mill Drive

Atlanta, GA 30318

13 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Innovative Cardiac Technologies, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (6 filings)

Surgical, medical, dental and veterinary apparatus and instruments

42
Computer & Scientific (4 filings)

Scientific and technological services; industrial analysis and research services

41
Education & Entertainment (2 filings)

Education; providing of training; entertainment; sporting and cultural activities

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Innovative Cardiac Technologies, LLC have?

Innovative Cardiac Technologies, LLC has 13 U.S. trademarks filed with the USPTO.

What trademark classes does Innovative Cardiac Technologies, LLC file in?

Innovative Cardiac Technologies, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What is Innovative Cardiac Technologies, LLC's trademark registration success rate?

Innovative Cardiac Technologies, LLC has a 0% trademark registration rate, with 0 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.